CryoLife (NYSE: CRY) reported Q3 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $64.6 million versus the consensus estimate of $61.84 million.

GUIDANCE:

CryoLife sees FY2018 EPS of $0.29-$0.32, versus the consensus of $0.32. CryoLife sees FY2018 revenue of $256-260 million, versus the consensus of $260.68 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.